Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk for severe hypoglycemia. The aim of this study was to assess the prevalence and determinants of self-reported IAH and severe hypoglycemia in a Dutch nationwide cohort of people with insulin-treated type 2 diabetes. Research design and methods Observational study of The Dutch Diabetes Pearl, a cohort of people with type 2 diabetes treated in primary, secondary and tertiary diabetes care centers. The presence of IAH and the occurrence of severe hypoglycemia in the past year, defined as an event requiring external help to re
Q2Q112-28Aims: Hypoglycemia constitutes a significant barrier to achieving glycemic control with ins...
Aims Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the fre...
Aims: Impaired awareness of hypoglycaemia (IAH) has been reported to affect up to a third of people ...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
Background: Impaired awareness of hypoglycaemia (IAH) predisposes affected patients to severe hypogl...
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients ...
Hypoglycemia and recurrent hypoglycemia may be associated with a significant increase in the risk of...
AIMS: Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the f...
Objectives Hypoglycemia is a common side effect of insulin therapy in type 1 and type 2 diabetes. Li...
Little is known about the frequency of significant hypoglycemic events in actual practice. Limited h...
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2...
Hypoglycaemia remains the most common metabolic adverse effect of insulin and sulfonylurea therapy i...
Hypoglycaemia is the most frequent and serious complication of insulin therapy and is three times mo...
Objective: To assess patients' awareness on management of hypoglycemic episodes and analyzing the pr...
Q2Q112-28Aims: Hypoglycemia constitutes a significant barrier to achieving glycemic control with ins...
Aims Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the fre...
Aims: Impaired awareness of hypoglycaemia (IAH) has been reported to affect up to a third of people ...
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycem...
Objective People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemi...
Background: Impaired awareness of hypoglycaemia (IAH) predisposes affected patients to severe hypogl...
Aims The present Malaysian cohort analysis determined the prevalence of hypoglycemia among patients ...
Hypoglycemia and recurrent hypoglycemia may be associated with a significant increase in the risk of...
AIMS: Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the f...
Objectives Hypoglycemia is a common side effect of insulin therapy in type 1 and type 2 diabetes. Li...
Little is known about the frequency of significant hypoglycemic events in actual practice. Limited h...
There are many misconceptions about the prevalence and effects of hypoglycemia in people with type 2...
Hypoglycaemia remains the most common metabolic adverse effect of insulin and sulfonylurea therapy i...
Hypoglycaemia is the most frequent and serious complication of insulin therapy and is three times mo...
Objective: To assess patients' awareness on management of hypoglycemic episodes and analyzing the pr...
Q2Q112-28Aims: Hypoglycemia constitutes a significant barrier to achieving glycemic control with ins...
Aims Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the fre...
Aims: Impaired awareness of hypoglycaemia (IAH) has been reported to affect up to a third of people ...